Events

ESMO 2021: EORTC-1508 Study

By ONA Editor September 23, 2021 No Comments

Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

About Author

Related Posts

Aspirin not a quick fix for preventing bowel cancer: Cochrane review

Low-dose aspirin does not reduce cancer incidence and may increase cancer-related mortality in older adults

ASCO GI 2026: Key gastrointestinal cancer trials shaping practice across CRC, upper GI and hepatobiliary disease

Leave A Reply Cancel Reply